1 Kim W, "Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population" 30 : 1413-1418, 2006
2 Knuts I, "Therapygenetics: 5-HTTLPR genotype predicts the response to exposure therapy for agoraphobia" 24 : 1222-1228, 2014
3 Lonsdorf TB, "The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism" 33 : 1479-1483, 2009
4 Kessler RC, "The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication" 63 : 415-424, 2006
5 Kim B, "The effects of the catechol-O-methyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder" 147 : 64-71, 2013
6 Woo JM, "The association between panic disorder and the L/L genotype of catechol-Omethyltransferase" 38 : 365-370, 2004
7 Qu HQ, "Statistical significance in genetic association studies" 33 : E266-E270, 2010
8 Hariri AR, "Serotonin transporter genetic variation and the response of the human amygdala" 297 : 400-403, 2002
9 강은호, "Serotonin Transporter and COMT Polymorphisms as Independent Predictors of Health-Related Quality of Life in Patients with Panic Disorder" 대한의학회 31 (31): 757-763, 2016
10 Choe AY, "Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-byenvironment interaction for panic disorder" 67 : 192-200, 2013
1 Kim W, "Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population" 30 : 1413-1418, 2006
2 Knuts I, "Therapygenetics: 5-HTTLPR genotype predicts the response to exposure therapy for agoraphobia" 24 : 1222-1228, 2014
3 Lonsdorf TB, "The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism" 33 : 1479-1483, 2009
4 Kessler RC, "The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication" 63 : 415-424, 2006
5 Kim B, "The effects of the catechol-O-methyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder" 147 : 64-71, 2013
6 Woo JM, "The association between panic disorder and the L/L genotype of catechol-Omethyltransferase" 38 : 365-370, 2004
7 Qu HQ, "Statistical significance in genetic association studies" 33 : E266-E270, 2010
8 Hariri AR, "Serotonin transporter genetic variation and the response of the human amygdala" 297 : 400-403, 2002
9 강은호, "Serotonin Transporter and COMT Polymorphisms as Independent Predictors of Health-Related Quality of Life in Patients with Panic Disorder" 대한의학회 31 (31): 757-763, 2016
10 Choe AY, "Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-byenvironment interaction for panic disorder" 67 : 192-200, 2013
11 Lee EH, "Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea" 26 : E120-E123, 2009
12 Shear MK, "Reliability and validity of the Panic Disorder Severity Scale: replication and extension" 35 : 293-296, 2001
13 Ohara K, "No association between anxiety disorders and catechol-O-methyltransferase polymorphism" 80 : 145-148, 1998
14 Kim H, "Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression" 296 : 1609-1618, 2006
15 Domschke K, "Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity" 144B : 667-673, 2007
16 Wang M, "Meta-Analysis of the COMT Val158Met polymorphism in major depressive disorder: effect of ethnicity" 11 : 434-445, 2016
17 Beck AT, "Manual for the beck anxiety inventory" The Psychological Corporation 1990
18 Gelernter J, "Linkage genome scan for loci predisposing to panic disorder or agoraphobia" 105 : 548-557, 2001
19 Blaya C, "Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis" 3 : 41-, 2007
20 Lim YJ, "Korean Panic Disorder Severity Scale: construct validity by confirmatory factor analysis" 24 : 95-102, 2007
21 Lemonde S, "Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide" 23 : 8788-8799, 2003
22 Konishi Y, "Gene×gene×gender interaction of BDNF and COMT genotypes associated with panic disorder" 51 : 119-125, 2014
23 Kang JI, "Genetic influence of COMT and BDNF gene polymorphisms on resilience in healthy college students" 68 : 174-180, 2013
24 Stein MB, "Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders" 33 : 312-319, 2008
25 Heils A, "Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene" 102 : 247-254, 1995
26 Kendler KS, "Fears and phobias: reliability and heritability" 29 : 539-553, 1999
27 Dudbridge F, "Estimation of significance thresholds for genomewide association scans" 32 : 227-234, 2008
28 Remy P, "Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system" 128 (128): 1314-1322, 2005
29 Peter H, "Childhood separation anxiety and separation events in women with agoraphobia with or without panic disorder" 50 : 941-944, 2005
30 Kim YR, "Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population" 18 : 820-825, 2008
31 Shulman R, "Catechol-O-methyl transferase activity in patients with depressive illness and anxiety states" 132 : 133-138, 1978
32 Mattay VS, "Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine" 100 : 6186-6191, 2003
33 Howe AS, "Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways" 21 : 665-679, 2016
34 Simon NM, "Bupropion sustained release for panic disorder" 37 : 66-72, 2003
35 Maron E, "Associations between serotonin-related gene polymorphisms and panic disorder" 8 : 261-266, 2005
36 Samochowiec J, "Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum" 128 : 21-26, 2004
37 Lachman HM, "Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome" 67 : 468-472, 1996
38 Lesch KP, "Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region" 274 : 1527-1531, 1996
39 Rothe C, "Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia" 7 : 189-192, 2004
40 Perna G, "Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition" 7 : 621-637, 2011
41 Beck AT, "An inventory for measuring depression" 4 : 561-571, 1961
42 Ishiguro H, "An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population" 51 : 333-335, 1997
43 Heinz A, "Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter" 8 : 20-21, 2005
44 Gallinat J, "Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing" 28 : 530-532, 2003
45 Tsuang M, "Agoraphobic behavior and panic attack: a study of male twins" 18 : 799-807, 2004
46 Stoltenberg SF, "Afraid to help: social anxiety partially mediates the association between 5-HTTLPR triallelic genotype and prosocial behavior" 8 : 400-406, 2013
47 Rhee MK, "A standardization study of Beck Depression Inventory I-Korean version (K-BDI): reliability and factor analysis" 4 : 77-95, 1995
48 Hettema JM, "A review and meta-analysis of the genetic epidemiology of anxiety disorders" 158 : 1568-1578, 2001
49 Yook SP, "A clinical study on the Korean version of beck anxiety inventory: comparative study of patient and non-patient" 16 : 185-197, 1997
50 Pezawas L, "5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression" 8 : 828-834, 2005